Effects of deferred versus immediate stenting on left ventricular function in patients with ST elevation myocardial infarction

Hyungdon Kook, Hyun-Jong Lee, Mi-Na Kim, Cheol Woong Yu, Je Sang Kim, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Kim, Ho-Jun Jang, Jin-Shik Park, Rak Kyeong Choi, Young Jin Choi, Yang Min Kim, Do-Sun Lim, Young Moo Ro, Hyungdon Kook, Hyun-Jong Lee, Mi-Na Kim, Cheol Woong Yu, Je Sang Kim, Hyung Joon Joo, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Kim, Ho-Jun Jang, Jin-Shik Park, Rak Kyeong Choi, Young Jin Choi, Yang Min Kim, Do-Sun Lim, Young Moo Ro

Abstract

Background: Previous studies have shown conflicting results on the benefits of deferred stenting (DS) in infarct size and the incidence of microvascular obstruction in patients with ST elevation myocardial infarction (STEMI). However, effect of DS on left ventricular (LV) function was not known. We aimed to evaluate whether DS improve LV function and relevant clinical outcomes after STEMI, using follow-up data from the INNOVATION study (NCT02324348).

Methods: In total, 114 patients were randomly assigned to DS group or immediate stenting (IS) group at a 1:1 ratio. LV functional remodeling indices and MACE (major adverse cardiac events: a composite of death, non-fatal MI, unplanned target vessel revascularization, or hospitalization due to heart failure) were compared between DS and IS groups.

Results: Serial echocardiographic analyses were completed in 89 subjects (78%). There were no significant changes in LV volume in either group. While LV ejection fraction and wall motion score index (WMSI) improved in both groups during follow-up, the increments were not statistically different between the 2 groups (4.3 ± 8.2 vs 3.2 ± 7.1, P = .504 for ΔLV ejection fraction; -0.16 ± 0.25 vs -0.16 ± 0.25, P = .99 for ΔWMSI). However, E/e'' was decreased and e' was increased only in the DS group (-3.31 ± 5.60 vs -0.46 ± 3.10, P = .005 for ΔE/e'; 0.77 ± 1.71 vs -0.22 ± 1.64, P = .009 for Δe'). The incidence of major adverse cardiac events was numerically lower in the DS group than in the IS group without a statistical significance at 1-year follow-up.

Conclusions: Routine DS improved LV diastolic function but not systolic function compared with IS in patients with STEMI.

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Figure 1
Figure 1
Flowchart of enrolled patients. MRI = magnetic resonance imaging, PCI = percutaneous coronary intervention, STEMI = ST elevation myocardial infarction, TIMI = thrombolysis in myocardial infarction.
Figure 2
Figure 2
Changes of left ventricular diastolic function during follow-up in deferred stenting group and immediate stenting group. Panel A shows the baseline and the follow-up of the E wave within each group. Panel B shows the baseline and the follow-up of the E/e′ within each group. DS = deferred stenting, IS = immediate stenting.
Figure 3
Figure 3
Kaplan–Meier curve of MACE between deferred stenting and immediate stenting groups during a median follow-up of 11.8 months. DS = deferred stenting, IS = immediate stenting, MACE = major adverse cardiac events.

References

    1. Ndrepepa G, Tiroch K, Fusaro M, et al. . 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010;55:2383–9.
    1. Svilaas T, Vlaar PJ, van der Horst IC, et al. . Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557–67.
    1. van Kranenburg M, Magro M, Thiele H, et al. . Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 2014;7:930–9.
    1. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281–92.
    1. Fearon WF, Low AF, Yong AS, et al. . Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 2013;127:2436–41.
    1. de Waha S, Desch S, Eitel I, et al. . Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010;31:2660–8.
    1. Kelbaek H, Hofsten DE, Kober L, et al. . Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet 2016;387:2199–206.
    1. Carrick D, Oldroyd KG, McEntegart M, et al. . A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol 2014;63:2088–98.
    1. Kim JS, Lee HJ, Woong Yu C, et al. . INNOVATION Study (impact of immediate stent implantation versus deferred stent implantation on infarct size and microvascular perfusion in patients with ST-Segment-elevation myocardial infarction). Circ Cardiovasc Interv 2016;9:e004101.
    1. Belle L, Motreff P, Mangin L, et al. . Comparison of immediate with delayed stenting using the minimalist immediate mechanical intervention approach in acute ST-segment-elevation myocardial infarction: The MIMI Study. Circ Cardiovasc Interv 2016;9:e003388.
    1. Tang L, Zhou SH, Hu XQ, Fang ZF, Shen XQ. Effect of delayed vs immediate stent implantation on myocardial perfusion and cardiac function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention with thrombus aspiration. Can J Cardiol 2011;27:541–7.
    1. Ke D, Zhong W, Fan L, Chen L. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden. Coron Artery Dis 2012;23:497–506.
    1. Lang RM, Badano LP, Mor-Avi V, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1.e14–39.e14.
    1. Nagueh SF, Smiseth OA, Appleton CP, et al. . Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277–314.
    1. Smabrekke B, Rinde LB, Hald EM, et al. . Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromso Study. J Thromb Haemost 2017;15:2344–51.
    1. Kastrati A, Mehilli J, Schuhlen H, et al. . A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 2004;350:232–8.
    1. Redfield MM, Jacobsen SJ, Burnett JC, Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194–202.
    1. Regenfus M, Schlundt C, Krahner R, et al. . Six-year prognostic value of microvascular obstruction after reperfused ST-elevation myocardial infarction as assessed by contrast-enhanced cardiovascular magnetic resonance. Am J Cardiol 2015;116:1022–7.
    1. de Waha S, Patel MR, Granger CB, et al. . Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 2017;38:3502–10.
    1. Weir RA, Murphy CA, Petrie CJ, et al. . Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging 2010;3:360–7.
    1. Bekkers SC, Backes WH, Kim RJ, et al. . Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol 2009;19:2904–12.
    1. Remmelink M, Sjauw KD, Henriques JP, et al. . Acute left ventricular dynamic effects of primary percutaneous coronary intervention from occlusion to reperfusion. J Am Coll Cardiol 2009;53:1498–502.
    1. Beitnes JO, Gjesdal O, Lunde K, et al. . Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study. Eur J Echocardiogr 2011;12:98–106.
    1. Taqueti VR, Solomon SD, Shah AM, et al. . Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2018;39:840–9.
    1. Bekkers SC, Yazdani SK, Virmani R, Waltenberger J. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. J Am Coll Cardiol 2010;55:1649–60.
    1. Jolicoeur EM, Dendukuri N, Belisle P, et al. . Immediate vs delayed stenting in st-elevation myocardial infarction: rationale and design of the international PRIMACY Bayesian Randomized Controlled Trial. Can J Cardiol 2020;36:1805–14.
    1. Nguyen TL, Phan J, Hogan J, et al. . Adverse diastolic remodeling after reperfused ST-elevation myocardial infarction: an important prognostic indicator. Am Heart J 2016;180:117–27.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit